P. Kaldis et al., HUMAN AND YEAST CDK-ACTIVATING KINASES (CAKS) DISPLAY DISTINCT SUBSTRATE SPECIFICITIES, Molecular biology of the cell, 9(9), 1998, pp. 2545-2560
Cell cycle progression is controlled by the sequential functions of cy
clin-dependent kinases (cdks). Cdk activation requires phosphorylation
of a key residue (on sites equivalent to Thr-160 in human cdk2) carri
ed out by the cdk-activating kinase (CAK). Human CAK has been identifi
ed as a p40(MO15)/cyclin H/MAT1 complex that also functions as part of
transcription factor III-I (TFIIH) where it phosphorylates multiple t
ranscriptional components including the C-terminal domain (CTD) of the
large subunit of RNA polymerase II. In contrast, CAK from budding yea
st consists of a single polypeptide (Cak1p), is not a component of TFI
IH, and lacks CTD kinase activity. Here we report that Cak1p and p40(M
O15) have strikingly different substrate specificities. Cak1p preferen
tially phosphorylated monomeric cdks, whereas p40(MO15) preferentially
phosphorylated cdk/cyclin complexes. Furthermore, p40(MO15) only phos
phorylated cdk6 bound to cyclin D3, whereas Cak1p recognized monomeric
cdk6 and cdk6 bound to cyclin D1, D2, or D3. We also found that cdk i
nhibitors, including p21(CIPI) p27(KIP1), P57(KIP2), p16(INK4a), and p
18(INK4c), could block phosphorylation by p40(MO15) but not phosphoryl
ation by Cak1p. Our results demonstrate that although both Cak1p and p
40(MO15) activate cdks by phosphorylating the same residue, the struct
ural mechanisms underlying the enzyme-substrate recognition differ gre
atly. Structural and physiological implications of these findings will
be discussed.